FDA is issuing new guidance for immediate implementation in accordance with 21 CFR 10.115(g)(2). FDA is concerned that large volume of saleable returns coupled with

FDA-UDI Comment Period closes December 19, 2012 Last month FDA published an amendment to its July 10, 2012 UDI proposed rule (77 FR 40736). Section